Armata Pharmaceuticals (ARMP)
Develops bacteriophage cocktails for serious antibiotic-resistant bacterial infections.
$4.20
After hours−0.02 (−0.47%)
At close$4.22(−0.94%)
Something off on this page? Send us feedback.
Next report
Nov 11, 26
in 50 days
EPS estimate
−$0.57
Revenue estimate
$450.0K
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.23−$0.20−$0.45−$0.74−$3.42−$3.16−$0.27Pending
Estimate−$0.35−$0.38−$0.39−$0.42−$0.19−$0.38−$0.45−$0.57
Surprise+34.3%+47.4%−15.4%−76.2%−1,700.0%−731.6%+39.3%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$1.2M$491.0K$2.2M$1.2M$1.1M$789.0K$2.5MPending
Estimate$1.6M$1.4M$1.4M$1.4M$740.0K$740.0K$400.0K$450.0K
Surprise−20.8%−64.4%+57.2%−16.0%+48.6%+6.6%+527.5%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2026 | −$0.40 | — | — |
| Nov 2026 | −$0.57 | — | — |
| Aug 2026 | −$0.45 | −$0.27 | +39.3% |
| May 2026 | −$0.38 | −$3.16 | −731.6% |
| Mar 2026 | −$0.19 | −$3.42 | −1,700.0% |
| Nov 2025 | −$0.42 | −$0.74 | −76.2% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2026 | −$0.40 | — | — | $515.0K | — | — | — |
| Nov 11, 2026 | −$0.57 | — | — | $450.0K | — | — | — |
| Aug 12, 2026 | −$0.45 | −$0.27 | +39.3% | $400.0K | $2.5M | +527.5% | +11.8% |
| May 13, 2026 | −$0.38 | −$3.16 | −731.6% | $740.0K | $789.0K | +6.6% | −2.0% |
| Mar 25, 2026 | −$0.19 | −$3.42 | −1,700.0% | $740.0K | $1.1M | +48.6% | +4.9% |
| Nov 12, 2025 | −$0.42 | −$0.74 | −76.2% | $1.4M | $1.2M | −16.0% | −0.9% |
| Aug 12, 2025 | |||||||
| May 14, 2025 | |||||||
| Mar 20, 2025 | |||||||
| Nov 13, 2024 | |||||||
| Aug 13, 2024 | |||||||
| May 7, 2024 | |||||||
| Mar 22, 2024 | |||||||
| Nov 14, 2023 | |||||||
| Aug 14, 2023 | |||||||
| May 11, 2023 | |||||||
| Mar 16, 2023 | |||||||
| Nov 9, 2022 | |||||||
| Aug 11, 2022 | |||||||
| May 12, 2022 | |||||||
| Mar 17, 2022 | |||||||
| Nov 10, 2021 | |||||||
| Aug 12, 2021 | |||||||
| May 13, 2021 | |||||||
| Mar 18, 2021 | |||||||
| Nov 12, 2020 | |||||||
| Aug 13, 2020 | |||||||
| May 14, 2020 | |||||||
| Mar 19, 2020 | |||||||
| Nov 12, 2019 | |||||||
| Aug 14, 2019 | |||||||
| May 6, 2019 | |||||||
| Mar 25, 2019 | |||||||
| Nov 8, 2018 | |||||||
| Aug 9, 2018 | |||||||
| May 15, 2018 | |||||||
| Mar 14, 2018 | |||||||
| Nov 14, 2017 | |||||||
| Aug 14, 2017 | |||||||
| May 15, 2017 | |||||||
| Mar 27, 2017 | |||||||
| Nov 10, 2016 | |||||||
| Aug 15, 2016 | |||||||
| May 12, 2016 | |||||||
| Mar 30, 2016 | |||||||
| Nov 16, 2015 | |||||||
| Aug 13, 2015 |